BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22862926)

  • 1. Incretin and pancreatic hormone secretion in Caucasian non-diabetic carriers of the TCF7L2 rs7903146 risk T allele.
    Færch K; Pilgaard K; Knop FK; Hansen T; Pedersen O; Jørgensen T; Holst JJ
    Diabetes Obes Metab; 2013 Jan; 15(1):91-5. PubMed ID: 22862926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men.
    Pilgaard K; Jensen CB; Schou JH; Lyssenko V; Wegner L; Brøns C; Vilsbøll T; Hansen T; Madsbad S; Holst JJ; Vølund A; Poulsen P; Groop L; Pedersen O; Vaag AA
    Diabetologia; 2009 Jul; 52(7):1298-307. PubMed ID: 19288077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common variants in the hERG (KCNH2) voltage-gated potassium channel are associated with altered fasting and glucose-stimulated plasma incretin and glucagon responses.
    Engelbrechtsen L; Mahendran Y; Jonsson A; Gjesing AP; Weeke PE; Jørgensen ME; Færch K; Witte DR; Holst JJ; Jørgensen T; Grarup N; Pedersen O; Vestergaard H; Torekov S; Kanters JK; Hansen T
    BMC Genet; 2018 Mar; 19(1):15. PubMed ID: 29548277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carriers of the TCF7L2 rs7903146 TT genotype have elevated levels of plasma glucose, serum proinsulin and plasma gastric inhibitory polypeptide (GIP) during a meal test.
    Gjesing AP; Kjems LL; Vestmar MA; Grarup N; Linneberg A; Deacon CF; Holst JJ; Pedersen O; Hansen T
    Diabetologia; 2011 Jan; 54(1):103-10. PubMed ID: 20957343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
    Tura A; Bagger JI; Ferrannini E; Holst JJ; Knop FK; Vilsbøll T; Mari A
    Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1123-1129. PubMed ID: 29162361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms.
    Schäfer SA; Tschritter O; Machicao F; Thamer C; Stefan N; Gallwitz B; Holst JJ; Dekker JM; 't Hart LM; Nijpels G; van Haeften TW; Häring HU; Fritsche A
    Diabetologia; 2007 Dec; 50(12):2443-50. PubMed ID: 17661009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postprandial responses of incretin and pancreatic hormones in non-diabetic patients with end-stage renal disease.
    Idorn T; Knop FK; Jørgensen M; Holst JJ; Hornum M; Feldt-Rasmussen B
    Nephrol Dial Transplant; 2014 Jan; 29(1):119-27. PubMed ID: 24078334
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Srinivasan S; Kaur V; Chamarthi B; Littleton KR; Chen L; Manning AK; Merino J; Thomas MK; Hudson M; Goldfine A; Florez JC
    Diabetes Care; 2018 Mar; 41(3):554-561. PubMed ID: 29326107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting and oral glucose-stimulated levels of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are highly familial traits.
    Gjesing AP; Ekstrøm CT; Eiberg H; Urhammer SA; Holst JJ; Pedersen O; Hansen T
    Diabetologia; 2012 May; 55(5):1338-45. PubMed ID: 22349073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth.
    Kim JY; Michaliszyn SF; Nasr A; Lee S; Tfayli H; Hannon T; Hughan KS; Bacha F; Arslanian S
    Diabetes Care; 2016 Aug; 39(8):1431-9. PubMed ID: 27293201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.
    Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1363-70. PubMed ID: 22319034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Reduced Incretin Effect Mediated by the rs7903146 Variant in the
    Galderisi A; Tricò D; Pierpont B; Shabanova V; Samuels S; Dalla Man C; Galuppo B; Santoro N; Caprio S
    Diabetes Care; 2020 Oct; 43(10):2553-2563. PubMed ID: 32788279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.
    Villareal DT; Robertson H; Bell GI; Patterson BW; Tran H; Wice B; Polonsky KS
    Diabetes; 2010 Feb; 59(2):479-85. PubMed ID: 19934000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of incretin on early-phase insulin secretion and glucose excursion.
    Shen J; Chen Z; Chen C; Zhu X; Han Y
    Endocrine; 2013 Oct; 44(2):403-10. PubMed ID: 23283820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incretin effect does not differ in trained and untrained, young, healthy men.
    Lund MT; Dalby S; Hartmann B; Helge J; Holst JJ; Dela F
    Acta Physiol (Oxf); 2014 Mar; 210(3):565-72. PubMed ID: 24354574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incretin effect in Korean subjects with normal glucose tolerance or type 2 diabetes.
    Oh TJ; Kim MY; Shin JY; Lee JC; Kim S; Park KS; Cho YM
    Clin Endocrinol (Oxf); 2014 Feb; 80(2):221-7. PubMed ID: 23405851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
    Nauck MA; Heimesaat MM; Orskov C; Holst JJ; Ebert R; Creutzfeldt W
    J Clin Invest; 1993 Jan; 91(1):301-7. PubMed ID: 8423228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incretin secretion in obese Korean children and adolescents with newly diagnosed type 2 diabetes.
    Park SH; Jung MH; Cho WK; Park MS; Suh BK
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):72-9. PubMed ID: 25903996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incretin levels in polycystic ovary syndrome.
    Vrbikova J; Hill M; Bendlova B; Grimmichova T; Dvorakova K; Vondra K; Pacini G
    Eur J Endocrinol; 2008 Aug; 159(2):121-7. PubMed ID: 18511472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.